• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[The treatment of borderline ovarian tumors and its prognosis].

作者信息

Li Z X, Qiu X F

机构信息

People's Hospital, Beijing Medical University.

出版信息

Zhonghua Fu Chan Ke Za Zhi. 1994 Apr;29(4):207-9, 251-2.

PMID:8082441
Abstract

Twenty patients with ovarian borderline epithelial tumors were analysed. The tumor in 9 patients were serous and in 11 patients mucinous in nature type. 15 cases were classified as of stage I, 3 cases of stage II and 2 cases of stage III, according to the FIGO staging. All pathologic slides were re-reviewed to confirm the diagnosis and no patients were lost to follow-up. Total hysterectomy and unilateral or bilateral salpingo-oophorectomy were done in 12 patients, among whom, 2 died of tumor recurrences. Unilateral adnexectomy was done in 8 patients, and none died of tumor recurrence. Fourteen patients received post operative chemotherapy 1-8 courses with PAC regimen, 12 patients were alive up to the present. Six patients did not receive chemotherapy and among these 3 with stage Ia were alive and 1 with stage Ib died of tumor recurrences. The survival rate of stage I was 92.3%. Our results indicated that the prognosis was closely related to clinical staging. We suggested that patients of stage I who wish to preserve childbearing function may be treated with unilateral salpingo-oophorectomy, and chemotherapy should be given to the patients with high risk factors. Because of the indolent nature of these tumors, long-term follow-up at least 10 years is necessary.

摘要

相似文献

1
[The treatment of borderline ovarian tumors and its prognosis].
Zhonghua Fu Chan Ke Za Zhi. 1994 Apr;29(4):207-9, 251-2.
2
The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.伴有非侵袭性种植的卵巢浆液性交界性肿瘤的复发率和总生存率与时间相关。
Am J Surg Pathol. 2006 Nov;30(11):1367-71. doi: 10.1097/01.pas.0000213294.81154.95.
3
[Borderline ovarian tumors. Retrospective analysis of 20 cases].[卵巢交界性肿瘤。20例回顾性分析]
Minerva Ginecol. 2001 Feb;53(1 Suppl 1):97-9.
4
Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.卵巢非小细胞神经内分泌癌:11例临床病理及免疫组化研究
Am J Surg Pathol. 2007 May;31(5):774-82. doi: 10.1097/01.pas.0000213422.53750.d1.
5
Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.卵巢卵黄囊瘤:临床病理特征和预后因素的评估。
Eur J Obstet Gynecol Reprod Biol. 2009 Oct;146(2):210-4. doi: 10.1016/j.ejogrb.2009.02.052. Epub 2009 May 5.
6
Management of epithelial ovarian tumors of low malignant potential.低恶性潜能上皮性卵巢肿瘤的管理
Gynecol Oncol. 1994 Dec;55(3 Pt 2):S52-61. doi: 10.1006/gyno.1994.1342.
7
Epithelial ovarian tumors of borderline malignancy: long-term follow-up.卵巢交界性上皮性肿瘤:长期随访
Gynecol Oncol. 1993 Sep;50(3):316-22. doi: 10.1006/gyno.1993.1218.
8
Conservative treatment of borderline ovarian tumors.卵巢交界性肿瘤的保守治疗
Obstet Gynecol. 1985 Sep;66(3):417-22.
9
Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.美法仑与顺铂联合化疗作为晚期卵巢癌初始治疗的随机试验:初步及长期结果——东部肿瘤协作组E2878研究
Cancer. 1996 Feb 15;77(4):733-42.
10
Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?卵巢肠型黏液性交界性肿瘤:我们是否准备好进行命名法的改变?
Int J Gynecol Pathol. 2010 Mar;29(2):108-12. doi: 10.1097/PGP.0b013e3181bc2706.